Risk factors for subarachnoid hemorrhage - An updated systematic review of epidemiological studies

被引:568
作者
Feigin, VL
Rinkel, GJE
Lawes, CMM
Algra, A
Bennett, DA
van Gijn, J
Anderson, CS
机构
[1] Univ Auckland, Fac Med & Hlth Sci, Clin Trials Res Unit, Auckland, New Zealand
[2] Univ Utrecht Hosp, Dept Neurol, Utrecht, Netherlands
[3] Univ Utrecht, Med Ctr, Julius Ctr Hlth Sci, Utrecht, Netherlands
[4] Univ Utrecht, Med Ctr, Primary Care Univ Dept, Utrecht, Netherlands
[5] Univ Oxford, Clin Trial Serv Unit, Oxford, England
[6] Univ Oxford, Epidemiol Studies Unit, Oxford, England
[7] Univ Oxford, Nuffield Dept Clin Med, Oxford, England
[8] Univ Sydney, George Inst Int Hlth, Sydney, NSW, Australia
关键词
meta-analysis; risk factors; subarachnoid hemorrhage;
D O I
10.1161/01.STR.0000190838.02954.e8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose - After a 1996 review from our group on risk factors for subarachnoid hemorrhage (SAH), much new information has become available. This article provides an updated overview of risk factors for SAH. Methods - An overview of all longitudinal and case-control studies of risk factors for SAH published in English from 1966 through March 2005. We calculated pooled relative risks (RRs) for longitudinal studies and odds ratios (ORs) for case-control studies, both with corresponding 95% CIs. Results - We included 14 longitudinal (5 new) and 23 (12 new) case-control studies. Overall, the studies included 3936 patients with SAH (892 cases in 14 longitudinal studies and 3044 cases in 23 case-control studies) for analysis. Statistically significant risk factors in longitudinal and case-control studies were current smoking (RR, 2.2 [1.3 to 3.6]; OR, 3.1 [2.7 to 3.5]), hypertension (RR, 2.5 [2.0 to 3.1]; OR, 2.6 [2.0 to 3.1]), and excessive alcohol intake (RR, 2.1 [1.5 to 2.8]; OR, 1.5 [1.3 to 1.8]). Nonwhite ethnicity was a less robust risk factor (RR, 1.8 [0.8 to 4.2]; OR, 3.4 [1.0 to 11.9]). Oral contraceptives did not affect the risk (RR, 5.4 [0.7 to 43.5]; OR, 0.8 [0.5 to 1.3]). Risk reductions were found for hormone replacement therapy (RR, 0.6 [0.2 to 1.5]; OR, 0.6 [0.4 to 0.8]), hypercholesterolemia (RR, 0.8 [0.6 to 1.2]; OR, 0.6 [0.4 to 0.9]), and diabetes (RR, 0.3 [0 to 2.2]; OR, 0.7 [0.5 to 0.8]). Data were inconsistent for lean body mass index (RR, 0.3 [0.2 to 0.4]; OR, 1.4 [1.0 to 2.0]) and rigorous exercise (RR, 0.5 [0.3 to 1.0]; OR, 1.2 [ 1.0 to 1.6]). In the studies included in the review, no other risk factors were available for the meta-analysis. Conclusions - Smoking, hypertension, and excessive alcohol remain the most important risk factors for SAH. The seemingly protective effects of white ethnicity compared to nonwhite ethnicity, hormone replacement therapy, hypercholesterolemia, and diabetes in the etiology of SAH are uncertain.
引用
收藏
页码:2773 / 2780
页数:8
相关论文
共 54 条
[1]   PHYSICAL-ACTIVITY IN OLDER MIDDLE-AGED MEN AND REDUCED RISK OF STROKE - THE HONOLULU-HEART-PROGRAM [J].
ABBOTT, RD ;
RODRIGUEZ, BL ;
BURCHFIEL, CM ;
CURB, JD .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 139 (09) :881-893
[2]   PREVALENCE OF DIABETES-MELLITUS AMONG PATIENTS WITH SUBARACHNOID HEMORRHAGE [J].
ADAMS, HP ;
PUTMAN, SF ;
KASSELL, NF ;
TORNER, JC .
ARCHIVES OF NEUROLOGY, 1984, 41 (10) :1033-1035
[3]   ARE CEREBRAL ANEURYSMS ATHEROSCLEROTIC [J].
ADAMSON, J ;
HUMPHRIES, SE ;
OSTERGAARD, JR ;
VOLDBY, B ;
RICHARDS, P ;
POWELL, JT .
STROKE, 1994, 25 (05) :963-966
[4]   Triggers of subarachnoid hemorrhage - Role of physical exertion, smoking, and alcohol in the Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS) [J].
Anderson, C ;
Mhurchu, CN ;
Scott, D ;
Bennett, D ;
Jamrozik, K ;
Hankey, G .
STROKE, 2003, 34 (07) :1771-1776
[5]   Active and passive smoking and the risk of subarachnoid hemorrhage - An international population-based case-control study [J].
Anderson, CS ;
Feigin, V ;
Bennett, D ;
Lin, RB ;
Hankey, G ;
Jamrozik, K .
STROKE, 2004, 35 (03) :633-637
[6]   Risk factors for intracerebral hemorrhage in the general population - A systematic review [J].
Ariesen, MJ ;
Claus, SP ;
Rinkel, GJE ;
Algra, A .
STROKE, 2003, 34 (08) :2060-2065
[8]  
Canhao P, 1994, J Cardiovasc Risk, V1, P155
[9]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[10]   ALCOHOL AND HEMORRHAGIC STROKE - THE HONOLULU-HEART-PROGRAM [J].
DONAHUE, RP ;
ABBOTT, RD ;
REED, DM ;
YANO, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 255 (17) :2311-2314